• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,502.12 579.48
( 0.75%)
Global Indices
Nasdaq
52,333.78 -6.42
(-0.01%)
Dow Jones
7,505.37 -14.99
(-0.20%)
Hang Seng
68,854.54 -1,620.42
(-2.30%)
Nikkei 225
10,664.80 186.46
(1.78%)
Forex
USD-INR
94.60 0.11
(0.12%)
EUR-INR
107.91 0.13
(0.12%)
GBP-INR
125.27 0.26
(0.21%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Indo National Ltd
Industry :  Dry Cells
BSE Code
ISIN Demat
Book Value()
504058
INE567A01028
282.8
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NIPPOBATRY
0
257.25
EPS(TTM)
Face Value()
Div & Yield %
0
5
1.09
 

Sanofi India jumps after Nippon India MF adds stake
Jun 15,2026
According to exchange data, Nippon India Mutual Fund purchased 2.64 lakh shares, or 1.15% equity, of Sanofi India at Rs 3,150 per share through a bulk deal on 12 June 2026.

The shares were sold by HDFC Life Insurance Company, which offloaded 2.75 lakh shares, or 1.19% equity, at the same price.

As of the March 2026 quarter, Nippon India Small Cap Fund held an aggregate 3.79% stake in Sanofi India, while HDFC Life Insurance Company's Shareholders Solvency Margin Account owned 1.47% of the pharmaceutical company.

Sanofi India is engaged in the manufacture and marketing of pharmaceutical products and vaccines. On a standalone basis, Sanofi India's net profit declined 14.14% to Rs 102.60 crore while net sales declined 11.87% to Rs 472.30 crore in Q4 March 2026 over Q4 March 2025.